Axel Hyrenius Wittsten
- Division of Clinical Genetics
- The pathogenetic mechanisms behind MLL-rearranged acute leukemia in infancy
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- Translational Genomic and Functional Studies of Leukemia
- LUCC: Lund University Cancer Centre
- Synthetic Immunology
1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Modular design of synthetic receptors for programmed gene regulation in cell therapies
(
- Contribution to journal › Article
-
Mark
Duplex Sequencing Uncovers Recurrent Low-frequency Cancer-associated Mutations in Infant and Childhood KMT2A-rearranged Acute Leukemia
(
- Contribution to journal › Article
- 2021
-
Mark
Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance
(
- Contribution to journal › Article
- 2019
-
Mark
FLT3
N676K
drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis
(
- Contribution to journal › Letter
- 2018
-
Mark
De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia
(
- Contribution to journal › Article
- 2017
-
Mark
Molecular Interrogation and Functional Studies of Acute Leukemia
2017)(
- Thesis › Doctoral thesis (compilation)
- 2016
-
Mark
Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia
(
- Contribution to journal › Article
-
Mark
Genomic profiling and directed ex vivo drug analysis of an unclassifiable myelodysplastic/myeloproliferative neoplasm progressing into acute myeloid leukemia
(
- Contribution to journal › Article
- 2014
-
Mark
HIF-1α can act as a tumor suppressor gene in murine Acute Myeloid Leukemia.
(
- Contribution to journal › Article